AGIO Stock Analysis: Buy, Sell, or Hold?
AGIO - Agios Pharmaceuticals, Inc.
$34.19
0.36 (1.06%)
▲
5d:
+15.55%
30d:
+20.05%
90d:
+25.1%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 07, 2026
Get Alerted When AGIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: AGIO is 11.1% above fair value ($30.78). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: AGIO is 11.1% above fair value ($30.78). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: AGIO is currently trading at $34.19, which is considered extended relative to its 30-day fair value range of $27.56 to $30.78.
Technical Outlook: Technically, AGIO is in a downtrend. Immediate support is located at $27.40, while resistance sits at $36.35.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.88 (+16.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AGIO is in a downtrend. Immediate support is located at $27.40, while resistance sits at $36.35.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.88 (+16.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$27.56 -
$30.78
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- BEARISH: Price significantly overextended (+11.1% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($39.88)
Fair Price Analysis
30-Day Fair Range
$27.56 -
$30.78
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$27.40
Resistance Level
$36.35
Current Trend
Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.70
Wall Street Target
$39.88
(+16.6%)
Revenue Growth (YoY)
86.1%
Share & Embed Analysis
Last updated: April 02, 2026 7:25 AM ET
Data refreshes hourly during market hours. Next update: 8:25 AM
Data refreshes hourly during market hours. Next update: 8:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGIO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Krishnan Viswanadhan
SELL
2959 shares
2026-03-05
Tsveta Milanova
SELL
2872 shares
2026-01-05
Brian Goff
SELL
18703 shares
2025-12-30
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 56 HOLD |
